Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.99 is 119% below its 5-year average of -0.45, near the low end of its 5-year range (-0.99–-0.13).
214.29% below its 12-month average of -0.32.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.46.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:02:39.072Z. Historical observations retain their original dates. Historical series through 2021-11-09.
EARNINGS PER SHARE (EPS)
-0.99
EARNINGS PER SHARE (EPS) AVG TTM
-0.32
EARNINGS PER SHARE (EPS) AVG 3Y
-0.47
EARNINGS PER SHARE (EPS) AVG 5Y
-0.45
EARNINGS PER SHARE (EPS) AVG 10Y
-0.53
EARNINGS PER SHARE (EPS) AVG 15Y
-0.76
EARNINGS PER SHARE (EPS) AVG 20Y
-0.69
CURRENT VS TTM AVG
-214.29%
CURRENT VS 3Y AVG
-109.52%
CURRENT VS 5Y AVG
-119.19%
CURRENT VS 10Y AVG
-88.08%
CURRENT VS 15Y AVG
-30.04%
CURRENT VS 20Y AVG
-43.67%
Harrow Health, Inc.
Market Cap
$1.13B
Earnings Per Share (EPS)
-0.99
TTM Avg
-0.32
3Y Avg
-0.47
5Y Avg
-0.45
Market Cap
$1.13B
Earnings Per Share (EPS)
1.69
TTM Avg
2.70
3Y Avg
2.53
5Y Avg
1.91
Market Cap
$1.13B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.04
3Y Avg
-2.04
5Y Avg
-2.04
Market Cap
$1.12B
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.19
3Y Avg
-0.27
5Y Avg
-0.18
Market Cap
$1.15B
Earnings Per Share (EPS)
0.04
TTM Avg
0.06
3Y Avg
0.01
5Y Avg
-0.18
Market Cap
$1.10B
Earnings Per Share (EPS)
0.08
TTM Avg
-1.62
3Y Avg
-0.53
5Y Avg
-0.05
Market Cap
$1.15B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
Market Cap
$1.09B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.22
3Y Avg
-3.17
5Y Avg
-2.78
Market Cap
$1.09B
Earnings Per Share (EPS)
-3.10
TTM Avg
-1.89
3Y Avg
-1.38
5Y Avg
-1.38
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harrow Health, Inc. (HROW) | $1.13B | -0.99 | -0.32 | -0.47 | -0.45 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 1.69 | 2.70 | 2.53 | 1.91 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | -2.04 | -2.04 | -2.04 |
| OPKO Health, Inc. (OPK)vs › | $1.12B | -0.10 | -0.19 | -0.27 | -0.18 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 0.04 | 0.06 | 0.01 | -0.18 |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.08 | -1.62 | -0.53 | -0.05 |
| Nektar Therapeutics (NKTR)vs › | $1.15B | N/A | -9.21 | -17.43 | -24.99 |
| Replimune Group, Inc. (REPL)vs › | $1.09B | -3.15 | -3.22 | -3.17 | -2.78 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -3.10 | -1.89 | -1.38 | -1.38 |
| IRadimed Corporation (IRMD)vs › | $1.08B | 1.79 | 1.65 | 1.42 | 1.09 |
Trailing EPS (TTM)
$-0.99
Forward EPS (Est.)
$-0.08
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.14 |
| 2024-12-31 | -0.49 |
| 2023-12-31 | -0.75 |
| 2022-12-31 | -0.51 |
| 2021-12-31 | -0.69 |
| 2020-12-31 | -0.13 |
| 2019-12-31 | 0.01 |
| 2018-12-31 | 0.67 |
| 2017-12-31 | -0.60 |
| 2016-12-31 | -1.50 |
| 2015-12-31 | -1.66 |
| 2014-12-31 | -1.11 |
| 2013-12-31 | -0.88 |
| 2012-12-31 | -1.24 |
| 2011-12-31 | -2.40 |
| 2010-12-31 | -6.41 |
| 2009-12-31 | -11.67 |
| 2008-12-31 | -8.92 |
| 2007-12-31 | -19.37 |
| 2006-12-31 | -0.25 |
| 2005-12-31 | -0.04 |
